Trial Profile
A Phase Ib, Multicenter, Open-label, Dose-finding Study of Patupilone Administered Intravenously Every 3 Weeks in Combination With Carboplatin AUC 6 in Adult Patients With Advanced Solid Tumors.
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 11 Dec 2020
Price :
$35
*
At a glance
- Drugs Patupilone (Primary) ; Carboplatin
- Indications Solid tumours
- Focus Adverse reactions
- 24 Mar 2011 Actual end date (August 2010) added as reported by ClinicalTrials.gov.
- 24 Mar 2011 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 16 Mar 2010 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.